BusinessAdamas Outlines Key 2017 Priorities and Highlights 2016 AchievementsBy Nasdaq OMXJan 9, 2017, 12:57 AM UTC
BusinessAdamas Pharmaceuticals Completes Phase 1 Clinical Trial of ADS-4101 for Treatment of Partial Onset Seizures in Patients with EpilepsyBy Nasdaq OMXJan 3, 2017, 9:53 PM UTC
